nodes	percent_of_prediction	percent_of_DWPC	metapath
Cromoglicic acid—Pericarditis—Vandetanib—thyroid cancer	0.0446	0.0446	CcSEcCtD
Cromoglicic acid—Hoarseness—Sorafenib—thyroid cancer	0.0296	0.0296	CcSEcCtD
Cromoglicic acid—Nephrotic syndrome—Sorafenib—thyroid cancer	0.0269	0.0269	CcSEcCtD
Cromoglicic acid—Haemoptysis—Vandetanib—thyroid cancer	0.026	0.026	CcSEcCtD
Cromoglicic acid—Dysphonia—Sorafenib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Cromoglicic acid—Lethargy—Vandetanib—thyroid cancer	0.0143	0.0143	CcSEcCtD
Cromoglicic acid—Glossitis—Sorafenib—thyroid cancer	0.0141	0.0141	CcSEcCtD
Cromoglicic acid—Dysphagia—Vandetanib—thyroid cancer	0.0121	0.0121	CcSEcCtD
Cromoglicic acid—Bronchospasm—Vandetanib—thyroid cancer	0.0119	0.0119	CcSEcCtD
Cromoglicic acid—Dysuria—Vandetanib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Cromoglicic acid—Neutropenia—Vandetanib—thyroid cancer	0.0113	0.0113	CcSEcCtD
Cromoglicic acid—Pollakiuria—Vandetanib—thyroid cancer	0.0112	0.0112	CcSEcCtD
Cromoglicic acid—Pericarditis—Epirubicin—thyroid cancer	0.0111	0.0111	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Vandetanib—thyroid cancer	0.011	0.011	CcSEcCtD
Cromoglicic acid—Stomatitis—Vandetanib—thyroid cancer	0.0105	0.0105	CcSEcCtD
Cromoglicic acid—Pericarditis—Doxorubicin—thyroid cancer	0.0103	0.0103	CcSEcCtD
Cromoglicic acid—Epistaxis—Vandetanib—thyroid cancer	0.0102	0.0102	CcSEcCtD
Cromoglicic acid—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Cromoglicic acid—Mood swings—Sorafenib—thyroid cancer	0.00894	0.00894	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Sorafenib—thyroid cancer	0.00862	0.00862	CcSEcCtD
Cromoglicic acid—Dysgeusia—Vandetanib—thyroid cancer	0.00825	0.00825	CcSEcCtD
Cromoglicic acid—Lacrimation—Epirubicin—thyroid cancer	0.00817	0.00817	CcSEcCtD
Cromoglicic acid—Dysphagia—Sorafenib—thyroid cancer	0.00816	0.00816	CcSEcCtD
Cromoglicic acid—Neutropenia—Sorafenib—thyroid cancer	0.00763	0.00763	CcSEcCtD
Cromoglicic acid—Lacrimation—Doxorubicin—thyroid cancer	0.00756	0.00756	CcSEcCtD
Cromoglicic acid—Cough—Vandetanib—thyroid cancer	0.00735	0.00735	CcSEcCtD
Cromoglicic acid—Convulsion—Vandetanib—thyroid cancer	0.0073	0.0073	CcSEcCtD
Cromoglicic acid—Chest pain—Vandetanib—thyroid cancer	0.00717	0.00717	CcSEcCtD
Cromoglicic acid—Arthralgia—Vandetanib—thyroid cancer	0.00717	0.00717	CcSEcCtD
Cromoglicic acid—Anxiety—Vandetanib—thyroid cancer	0.00715	0.00715	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00713	0.00713	CcSEcCtD
Cromoglicic acid—Stomatitis—Sorafenib—thyroid cancer	0.00709	0.00709	CcSEcCtD
Cromoglicic acid—Oedema—Vandetanib—thyroid cancer	0.00688	0.00688	CcSEcCtD
Cromoglicic acid—Epistaxis—Sorafenib—thyroid cancer	0.00686	0.00686	CcSEcCtD
Cromoglicic acid—Haemoptysis—Epirubicin—thyroid cancer	0.00649	0.00649	CcSEcCtD
Cromoglicic acid—Neuritis—Epirubicin—thyroid cancer	0.00644	0.00644	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00626	0.00626	CcSEcCtD
Cromoglicic acid—Insomnia—Vandetanib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Cromoglicic acid—Paraesthesia—Vandetanib—thyroid cancer	0.00617	0.00617	CcSEcCtD
Cromoglicic acid—Dyspnoea—Vandetanib—thyroid cancer	0.00613	0.00613	CcSEcCtD
Cromoglicic acid—Tinnitus—Sorafenib—thyroid cancer	0.00609	0.00609	CcSEcCtD
Cromoglicic acid—Dyspepsia—Vandetanib—thyroid cancer	0.00605	0.00605	CcSEcCtD
Cromoglicic acid—Haemoptysis—Doxorubicin—thyroid cancer	0.00601	0.00601	CcSEcCtD
Cromoglicic acid—Neuritis—Doxorubicin—thyroid cancer	0.00595	0.00595	CcSEcCtD
Cromoglicic acid—Stinging—Epirubicin—thyroid cancer	0.00593	0.00593	CcSEcCtD
Cromoglicic acid—Fatigue—Vandetanib—thyroid cancer	0.00593	0.00593	CcSEcCtD
Cromoglicic acid—Pain—Vandetanib—thyroid cancer	0.00588	0.00588	CcSEcCtD
Cromoglicic acid—Constipation—Vandetanib—thyroid cancer	0.00588	0.00588	CcSEcCtD
Cromoglicic acid—Dysphonia—Epirubicin—thyroid cancer	0.00584	0.00584	CcSEcCtD
Cromoglicic acid—Erythema—Sorafenib—thyroid cancer	0.00568	0.00568	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00562	0.00562	CcSEcCtD
Cromoglicic acid—Dysgeusia—Sorafenib—thyroid cancer	0.00557	0.00557	CcSEcCtD
Cromoglicic acid—Stinging—Doxorubicin—thyroid cancer	0.00549	0.00549	CcSEcCtD
Cromoglicic acid—Body temperature increased—Vandetanib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Cromoglicic acid—Abdominal pain—Vandetanib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Cromoglicic acid—Dysphonia—Doxorubicin—thyroid cancer	0.0054	0.0054	CcSEcCtD
Cromoglicic acid—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00532	0.00532	CcSEcCtD
Cromoglicic acid—Anaemia—Sorafenib—thyroid cancer	0.00525	0.00525	CcSEcCtD
Cromoglicic acid—Cough increased—Epirubicin—thyroid cancer	0.00525	0.00525	CcSEcCtD
Cromoglicic acid—Glossitis—Epirubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Cromoglicic acid—Lacrimation increased—Epirubicin—thyroid cancer	0.00521	0.00521	CcSEcCtD
Cromoglicic acid—Angioedema—Sorafenib—thyroid cancer	0.00519	0.00519	CcSEcCtD
Cromoglicic acid—Cough—Sorafenib—thyroid cancer	0.00496	0.00496	CcSEcCtD
Cromoglicic acid—Asthenia—Vandetanib—thyroid cancer	0.00493	0.00493	CcSEcCtD
Cromoglicic acid—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00492	0.00492	CcSEcCtD
Cromoglicic acid—Cough increased—Doxorubicin—thyroid cancer	0.00486	0.00486	CcSEcCtD
Cromoglicic acid—Myalgia—Sorafenib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Cromoglicic acid—Arthralgia—Sorafenib—thyroid cancer	0.00484	0.00484	CcSEcCtD
Cromoglicic acid—Glossitis—Doxorubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Cromoglicic acid—Lacrimation increased—Doxorubicin—thyroid cancer	0.00482	0.00482	CcSEcCtD
Cromoglicic acid—Hepatocellular injury—Epirubicin—thyroid cancer	0.00481	0.00481	CcSEcCtD
Cromoglicic acid—Diarrhoea—Vandetanib—thyroid cancer	0.0047	0.0047	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Sorafenib—thyroid cancer	0.00464	0.00464	CcSEcCtD
Cromoglicic acid—Dizziness—Vandetanib—thyroid cancer	0.00455	0.00455	CcSEcCtD
Cromoglicic acid—Hepatocellular injury—Doxorubicin—thyroid cancer	0.00445	0.00445	CcSEcCtD
Cromoglicic acid—Rash maculo-papular—Epirubicin—thyroid cancer	0.00437	0.00437	CcSEcCtD
Cromoglicic acid—Rash—Vandetanib—thyroid cancer	0.00434	0.00434	CcSEcCtD
Cromoglicic acid—Dermatitis—Vandetanib—thyroid cancer	0.00433	0.00433	CcSEcCtD
Cromoglicic acid—Headache—Vandetanib—thyroid cancer	0.00431	0.00431	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Cromoglicic acid—Dyspnoea—Sorafenib—thyroid cancer	0.00414	0.00414	CcSEcCtD
Cromoglicic acid—Nausea—Vandetanib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Cromoglicic acid—Dyspepsia—Sorafenib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Cromoglicic acid—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Cromoglicic acid—Fatigue—Sorafenib—thyroid cancer	0.004	0.004	CcSEcCtD
Cromoglicic acid—Photosensitivity—Epirubicin—thyroid cancer	0.00397	0.00397	CcSEcCtD
Cromoglicic acid—Pain—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Cromoglicic acid—Constipation—Sorafenib—thyroid cancer	0.00397	0.00397	CcSEcCtD
Cromoglicic acid—Vascular purpura—Epirubicin—thyroid cancer	0.0039	0.0039	CcSEcCtD
Cromoglicic acid—Eye pain—Epirubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00379	0.00379	CcSEcCtD
Cromoglicic acid—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Cromoglicic acid—Urticaria—Sorafenib—thyroid cancer	0.00368	0.00368	CcSEcCtD
Cromoglicic acid—Photosensitivity—Doxorubicin—thyroid cancer	0.00368	0.00368	CcSEcCtD
Cromoglicic acid—Abdominal pain—Sorafenib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Cromoglicic acid—Body temperature increased—Sorafenib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Cromoglicic acid—Purpura—Epirubicin—thyroid cancer	0.00362	0.00362	CcSEcCtD
Cromoglicic acid—Vascular purpura—Doxorubicin—thyroid cancer	0.00361	0.00361	CcSEcCtD
Cromoglicic acid—Eye pain—Doxorubicin—thyroid cancer	0.00357	0.00357	CcSEcCtD
Cromoglicic acid—Lethargy—Epirubicin—thyroid cancer	0.00356	0.00356	CcSEcCtD
Cromoglicic acid—Migraine—Epirubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Cromoglicic acid—Affect lability—Epirubicin—thyroid cancer	0.00343	0.00343	CcSEcCtD
Cromoglicic acid—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Sorafenib—thyroid cancer	0.00342	0.00342	CcSEcCtD
Cromoglicic acid—Purpura—Doxorubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Cromoglicic acid—Asthenia—Sorafenib—thyroid cancer	0.00333	0.00333	CcSEcCtD
Cromoglicic acid—Mood swings—Epirubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Cromoglicic acid—Lethargy—Doxorubicin—thyroid cancer	0.00329	0.00329	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Epirubicin—thyroid cancer	0.00319	0.00319	CcSEcCtD
Cromoglicic acid—Affect lability—Doxorubicin—thyroid cancer	0.00318	0.00318	CcSEcCtD
Cromoglicic acid—Migraine—Doxorubicin—thyroid cancer	0.00318	0.00318	CcSEcCtD
Cromoglicic acid—Diarrhoea—Sorafenib—thyroid cancer	0.00317	0.00317	CcSEcCtD
Cromoglicic acid—Dizziness—Sorafenib—thyroid cancer	0.00307	0.00307	CcSEcCtD
Cromoglicic acid—Mood swings—Doxorubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Cromoglicic acid—Dysphagia—Epirubicin—thyroid cancer	0.00301	0.00301	CcSEcCtD
Cromoglicic acid—Eosinophilia—Epirubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00295	0.00295	CcSEcCtD
Cromoglicic acid—Rash—Sorafenib—thyroid cancer	0.00292	0.00292	CcSEcCtD
Cromoglicic acid—Dermatitis—Sorafenib—thyroid cancer	0.00292	0.00292	CcSEcCtD
Cromoglicic acid—Headache—Sorafenib—thyroid cancer	0.00291	0.00291	CcSEcCtD
Cromoglicic acid—Pancytopenia—Epirubicin—thyroid cancer	0.00286	0.00286	CcSEcCtD
Cromoglicic acid—Dysuria—Epirubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Cromoglicic acid—Neutropenia—Epirubicin—thyroid cancer	0.00282	0.00282	CcSEcCtD
Cromoglicic acid—Dysphagia—Doxorubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Cromoglicic acid—Pollakiuria—Epirubicin—thyroid cancer	0.00278	0.00278	CcSEcCtD
Cromoglicic acid—Eosinophilia—Doxorubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Cromoglicic acid—Nausea—Sorafenib—thyroid cancer	0.00276	0.00276	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00275	0.00275	CcSEcCtD
Cromoglicic acid—Drowsiness—Epirubicin—thyroid cancer	0.00269	0.00269	CcSEcCtD
Cromoglicic acid—Pancytopenia—Doxorubicin—thyroid cancer	0.00265	0.00265	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Cromoglicic acid—Stomatitis—Epirubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Cromoglicic acid—Dysuria—Doxorubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Cromoglicic acid—Neutropenia—Doxorubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Cromoglicic acid—Pollakiuria—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Cromoglicic acid—Epistaxis—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Cromoglicic acid—Drowsiness—Doxorubicin—thyroid cancer	0.00249	0.00249	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Cromoglicic acid—Stomatitis—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Epirubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Cromoglicic acid—Pharyngitis—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Cromoglicic acid—Epistaxis—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Cromoglicic acid—Tinnitus—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Cromoglicic acid—Pharyngitis—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Cromoglicic acid—Erythema—Epirubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Cromoglicic acid—Tinnitus—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Cromoglicic acid—Flatulence—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Cromoglicic acid—Tension—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Cromoglicic acid—Dysgeusia—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Cromoglicic acid—Nervousness—Epirubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Cromoglicic acid—Erythema—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Cromoglicic acid—Anaemia—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Cromoglicic acid—Flatulence—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Cromoglicic acid—Tension—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Cromoglicic acid—Dysgeusia—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Cromoglicic acid—Malaise—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Cromoglicic acid—Nervousness—Doxorubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Cromoglicic acid—Vertigo—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Cromoglicic acid—Palpitations—Epirubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Cromoglicic acid—Cough—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Cromoglicic acid—Convulsion—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Cromoglicic acid—Anaemia—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Cromoglicic acid—Arthralgia—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Cromoglicic acid—Chest pain—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Cromoglicic acid—Myalgia—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Cromoglicic acid—Anxiety—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Cromoglicic acid—Discomfort—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Cromoglicic acid—Malaise—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cromoglicic acid—Vertigo—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Cromoglicic acid—Palpitations—Doxorubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Cromoglicic acid—Oedema—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Cromoglicic acid—Cough—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Cromoglicic acid—Convulsion—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Cromoglicic acid—Tachycardia—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Cromoglicic acid—Arthralgia—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cromoglicic acid—Chest pain—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cromoglicic acid—Myalgia—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cromoglicic acid—Anxiety—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Cromoglicic acid—Discomfort—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Cromoglicic acid—Hypotension—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Cromoglicic acid—Oedema—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Cromoglicic acid—Insomnia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Cromoglicic acid—Tachycardia—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Cromoglicic acid—Paraesthesia—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Cromoglicic acid—Dyspnoea—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Cromoglicic acid—Somnolence—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Cromoglicic acid—Dyspepsia—Epirubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Cromoglicic acid—Hypotension—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cromoglicic acid—Fatigue—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Cromoglicic acid—Pain—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Cromoglicic acid—Constipation—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Cromoglicic acid—Insomnia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Cromoglicic acid—Paraesthesia—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Cromoglicic acid—Dyspnoea—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Somnolence—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Cromoglicic acid—Dyspepsia—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Cromoglicic acid—Fatigue—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Cromoglicic acid—Urticaria—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Pain—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Constipation—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Body temperature increased—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Abdominal pain—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Cromoglicic acid—Urticaria—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Cromoglicic acid—Abdominal pain—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Cromoglicic acid—Body temperature increased—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Cromoglicic acid—Asthenia—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Cromoglicic acid—Diarrhoea—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Cromoglicic acid—Asthenia—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Cromoglicic acid—Dizziness—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Cromoglicic acid—Diarrhoea—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Cromoglicic acid—Rash—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cromoglicic acid—Dermatitis—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Cromoglicic acid—Headache—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Cromoglicic acid—Dizziness—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Cromoglicic acid—Nausea—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Cromoglicic acid—Rash—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Cromoglicic acid—Dermatitis—Doxorubicin—thyroid cancer	0.000999	0.000999	CcSEcCtD
Cromoglicic acid—Headache—Doxorubicin—thyroid cancer	0.000994	0.000994	CcSEcCtD
Cromoglicic acid—Nausea—Doxorubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
